Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)
Recruiting
Early Phase 1
Interventional Study
Primary Biliary Cholangitis (PBC)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 15 (estimated)
- Sponsor
- Xijing Hospital of Digestive Diseases · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Fenofibrate in Subjects with Primary Biliary Cholangitis (PBC)
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Must have given written informed consent (signed and dated)
2. Completed in a PBC study with fenofibrate(NCT06591455)
3. Females of reproductive potential must use at least one barrier contraceptive and a second effective birth control method during the study and for at least…
Contacts
No contact information available.